{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:01:43Z","timestamp":1760148103705,"version":"3.44.0"},"reference-count":23,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,1,23]]},"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>We present the case of a teenaged boy who attended our Ear, Nose and Throat Emergency clinic with a left-sided lower motor neuron (LMN) facial nerve paralysis associated with sensory loss in the distribution of the ophthalmic (V1) and maxillary (V2) divisions of the trigeminal nerve. This happened 3 days following a first dose of the Pfizer-BioNTech BNT162b2 vaccine. He had a House-Brackmann grade V facial palsy, with marked inability to close the left eye. He was treated with a 10-day course of oral steroids and referred to ophthalmology for eye care. He had an MRI scan of the head, which revealed no space occupying lesions or other abnormalities. Over the 6-week period of follow-up, the patient\u2019s V1 and V2 sensation gradually resolved, along with improvement of his LMN facial nerve palsy to House-Brackmann grade 3. Despite the potential temporal relationship, it is not possible to establish a causal relationship between the patient\u2019s symptoms and the Pfizer-BioNTech BNT162b2 vaccine, thus further research is required.<\/jats:p>","DOI":"10.1136\/bcr-2022-253302","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T11:21:53Z","timestamp":1675077713000},"page":"e253302","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Concurrent facial and trigeminal nerve palsies in a child following COVID-19 vaccination with the Pfizer vaccine"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-355X","authenticated-orcid":false,"given":"Carine","family":"Moezinia","sequence":"first","affiliation":[{"name":"Department of Medicine, Royal Free Hospital, London, UK"},{"name":"Department of Otorhinolaryngology, Wexham Park Hospital, Slough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor B","family":"Harbinson","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Wexham Park Hospital, Slough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M","family":"Maweni","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Wexham Park Hospital, Slough, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"2025082801333946000_16.1.e253302.1","unstructured":"GOV.UK . Information for UK recipients on pfizer\/biontech COVID-19 vaccine (Regulation 174). Available: https:\/\/www.gov.uk\/government\/publications\/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19\/information-for-uk-recipients-on-pfizerbiontech-covid-19-vaccine [Accessed 12 Jun 2022]."},{"key":"2025082801333946000_16.1.e253302.2","unstructured":"GOV.UK . COVID-19 mRNA pfizer- biontech vaccine analysis. 2022. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1072043\/COVID-19_mRNA_Pfizer-_BioNTech_vaccine_analysis_print.pdf"},{"key":"2025082801333946000_16.1.e253302.3","unstructured":"GOV.UK . Coronavirus vaccine - weekly summary of yellow card reporting. 2022. Available: https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting [Accessed 12 Jun 2022]."},{"key":"2025082801333946000_16.1.e253302.4","unstructured":"Covid PB . Vaccines and related biological products advisory committee meeting December 10; 2020. 53."},{"key":"2025082801333946000_16.1.e253302.5","unstructured":"GOV.UK . The MHRA concludes positive safety profile for pfizer\/biontech vaccine in 12- to 15-year-olds. 2022. Available: https:\/\/www.gov.uk\/government\/news\/the-mhra-concludes-positive-safety-profile-for-pfizerbiontech-vaccine-in-12-to-15-year-olds [Accessed 12 Jun 2022]."},{"key":"2025082801333946000_16.1.e253302.6","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.937511","article-title":"Concurrent Bell\u2019s palsy and facial pain improving with multimodal chiropractic therapy: a case report and literature review","volume":"23","author":"Chu","year":"2022","journal-title":"Am J Case Rep"},{"key":"2025082801333946000_16.1.e253302.7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.21.2383"},{"key":"2025082801333946000_16.1.e253302.8","first-page":"291","article-title":"L\u2019atteinte trig\u00e9minale sensitive au cours de la paralysie faciale p\u00e9riph\u00e9rique essentielle [trigeminal sensory involvement in bell\u2019s palsy (author\u2019s transl)]","volume":"9","author":"Lapresle","year":"1980","journal-title":"Nouv Presse Med"},{"key":"2025082801333946000_16.1.e253302.9","first-page":"143","article-title":"Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination","volume":"23","author":"Shemer","year":"2021","journal-title":"Isr Med Assoc J"},{"key":"2025082801333946000_16.1.e253302.10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamaoto.2021.1259","article-title":"Association of COVID-19 vaccination and facial nerve palsy: a case-control study","volume":"147","author":"Shemer","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2025082801333946000_16.1.e253302.11","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000001148"},{"key":"2025082801333946000_16.1.e253302.12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00415-021-10780-7","article-title":"COVID-19 mRNA vaccination leading to CNS inflammation: a case series","volume":"269","author":"Khayat-Khoei","year":"2022","journal-title":"J Neurol"},{"key":"2025082801333946000_16.1.e253302.13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00415-021-10648-w","article-title":"First manifestation of multiple sclerosis after immunization with the pfizer-biontech COVID-19 vaccine","volume":"269","author":"Havla","year":"2022","journal-title":"J Neurol"},{"key":"2025082801333946000_16.1.e253302.14","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410120202"},{"key":"2025082801333946000_16.1.e253302.15","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.00361","article-title":"Do vaccines have a role as a cause of autoimmune neurological syndromes?","volume":"8","author":"Principi","year":"2020","journal-title":"Front Public Health"},{"key":"2025082801333946000_16.1.e253302.16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/B:DDAS.0000026389.56819.0c","article-title":"Bell\u2019s palsy: a rare complication of interferon therapy for hepatitis C","volume":"49","author":"Hwang","year":"2004","journal-title":"Dig Dis Sci"},{"key":"2025082801333946000_16.1.e253302.17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jamainternmed.2021.2219","article-title":"Association of facial paralysis with mRNA COVID-19 vaccines: a disproportionality analysis using the World Health Organization pharmacovigilance database","volume":"181","author":"Renoud","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2025082801333946000_16.1.e253302.18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13365-021-01030-7","article-title":"A case of trigeminal neuralgia developing after a COVID-19 vaccination","volume":"28","author":"Kaya","year":"2022","journal-title":"J Neurovirol"},{"key":"2025082801333946000_16.1.e253302.19","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-242344","article-title":"Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19","volume":"14","author":"Narasimhalu","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2025082801333946000_16.1.e253302.20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S1473-3099(21)00273-5","article-title":"Bell\u2019s palsy and SARS-CoV-2 vaccines-an unfolding story","volume":"21","author":"Cirillo","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025082801333946000_16.1.e253302.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00451-5"},{"key":"2025082801333946000_16.1.e253302.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100236"},{"key":"2025082801333946000_16.1.e253302.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072006"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-253302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:33:51Z","timestamp":1756370031000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-253302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,30]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1136\/bcr-2022-253302"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-253302","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}